According to Foresight News, Bio Protocol has announced the commencement of its V2 phase, introducing Launcher V2. This new feature enables users to engage in the sale of low-market-cap BioAgents, IP-Tokens, and BioDAOs. Additionally, users can stake BIO and DeSci tokens to earn BioXP and participate in activities to accumulate points. These points can be used to access new sales.